Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

NCT01126866 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped recruiting inadequate

Conditions

Colorectal Carcinoma

Interventions

DRUG: intensified chemotherapy (FOLFOXIRI/Bevacizumab)

Sponsor

National Center for Tumor Diseases, Heidelberg

Collaborators

[object Object]
[object Object]